Literature DB >> 35224433

Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference.

Amie J Goodin1,2,3, Debbie L Wilson1, Robert L Cook3,4,5, Yan Wang3,4, Joshua Brown1,2,3, Almut G Winterstein1,2,3,4.   

Abstract

The Cannabis Clinical Outcomes Research Conference (CCORC) 2021 was held virtually on April 8 and 9, 2021. The conference was hosted by the Consortium for Medical Marijuana Clinical Outcomes Research, a research organization instituted by the state legislature of Florida in the United States. The inaugural annual CCORC 2021 was organized as a scientific meeting to foster and disseminate research on medical marijuana (MM) clinical outcomes, while promoting engagement among MM researchers, patients, clinicians, policymakers, and industry partners. Key conference themes included: (a) the disconnect between policy, practice, and evidence and steps towards reconciliation, (b) approaches to overcome common barriers to MM research, and (c) the use of focused translational approaches utilizing both mechanistic and clinical research methodology to tackle the complexities of MM outcomes. CCORC 2022 is planned for spring 2022 in Orlando, Florida, United States.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Cannabis; Conference proceedings; Marijuana clinical outcomes; Medical marijuana

Year:  2021        PMID: 35224433      PMCID: PMC8832197          DOI: 10.1159/000519037

Source DB:  PubMed          Journal:  Med Cannabis Cannabinoids        ISSN: 2504-3889


  5 in total

1.  Cannabinoid-opioid interaction in chronic pain.

Authors:  D I Abrams; P Couey; S B Shade; M E Kelly; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2011-11-02       Impact factor: 6.875

2.  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Authors:  D I Abrams; C A Jay; S B Shade; H Vizoso; H Reda; S Press; M E Kelly; M C Rowbotham; K L Petersen
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

3.  The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir.

Authors:  Bradley W Kosel; Francesca T Aweeka; Neal L Benowitz; Starley B Shade; Joan F Hilton; Patricia S Lizak; Donald I Abrams
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

4.  A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.

Authors:  Sebastian Jugl; Aimalohi Okpeku; Brianna Costales; Earl J Morris; Golnoosh Alipour-Haris; Juan M Hincapie-Castillo; Nichole E Stetten; Ruba Sajdeya; Shailina Keshwani; Verlin Joseph; Yahan Zhang; Yun Shen; Lauren Adkins; Almut G Winterstein; Amie Goodin
Journal:  Med Cannabis Cannabinoids       Date:  2021-02-25

5.  Vaporization as a smokeless cannabis delivery system: a pilot study.

Authors:  D I Abrams; H P Vizoso; S B Shade; C Jay; M E Kelly; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2007-04-11       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.